Actuate Therapeutics Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $19.3M

  • Investors
  • 7

Actuate Therapeutics General Information

Description

Operator of a biopharmaceutical company focused on the development of compounds for use in the treatment of cancer, and inflammatory diseases leading to fibrosis. The company is developing novel therapeutics that target Glycogen Synthase which has implications in conditions, including cancer, Alzheimer's disease, bipolar disorder, diabetes mellitus type II, and inflammatory conditions leading to fibrosis, enabling healthcare providers to treat cancer and fibrotic diseases.

Contact Information

Website
www.actuatetherapeutics.com
Formerly Known As
Apotheca Therapeutics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 1751 River Run
  • Suite 400
  • Fort Worth, TX 76107
  • United States
+1 (847) 000-0000

Actuate Therapeutics Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Actuate Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series C) 15-Dec-2022 $19.3M 000.00 Completed Clinical Trials - Phase 2
5. Later Stage VC (Series B3) 15-Jan-2021 00000 000.00 Completed Clinical Trials - Phase 2
4. Later Stage VC (Series B) 10-Dec-2020 000.00 000.00 000.00 Completed Clinical Trials - Phase 2
3. Early Stage VC (Series B3) 12-Nov-2019 00.00 000.00 000.00 Completed Clinical Trials - Phase 2
2. Early Stage VC (Series B) 30-Apr-2019 $21.7M $24.7M 000.00 Completed Clinical Trials - Phase 2
1. Early Stage VC (Series A) 15-Jun-2017 $3M $3M 000 Completed Clinical Trials - Phase 2
To view Actuate Therapeutics’s complete valuation and funding history, request access »

Actuate Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B-4 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series B-3 0,000,000 00.000000 00 00 00 00 00 00.000
Series B-2 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series B-1 4,133,477 $0.000001 8% $3.66 $3.66 1x $3.66 26.79%
Series A 1,983,663 $0.000001 8% $2 $2 1x $2 12.86%
To view Actuate Therapeutics’s complete cap table history, request access »

Actuate Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biopharmaceutical company focused on the development of compounds for use in the treatment of cancer, and
Drug Discovery
Fort Worth, TX
6 As of 2022
000.00
00000000000 000.00

00000

nim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea comm
0000000000000
Geneva, Switzerland
00 As of 0000
00000
00000000000 00000

000000

t in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint
0000 000000000
Lebanon, NH
000 As of 0000
00000
0000000000 0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Actuate Therapeutics Competitors (63)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Light Chain Bioscience Private Equity-Backed Geneva, Switzerland 00 00000 00000000000 00000
000000 Venture Capital-Backed Lebanon, NH 000 00000 0000000000 0 00000
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
00000 000000000000 Formerly VC-backed New York, NY 00 000.00 000000000000 000.00
0000000 0000000000 Formerly VC-backed San Diego, CA 00 00000 000000000 00000
You’re viewing 5 of 63 competitors. Get the full list »

Actuate Therapeutics Patents

  • 31

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 8

    Granted

  • 23

    Pending

  • 000

    Expiring in next 12 mo

Actuate Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3166251-A1 Compounds for the treatment of myelofibrosis Pending 26-Dec-2019 000000000
US-20230062278-A1 Compounds for the treatment of myelofibrosis Pending 26-Dec-2019 0000000000
AU-2020415440-A1 Compounds for the treatment of myelofibrosis Pending 26-Dec-2019 000000000
EP-4081213-A1 Compounds for the treatment of myelofibrosis Pending 26-Dec-2019 000000000
US-20220034766-A1 Immunohistochemical staining for gsk-3 Pending 12-Dec-2018 G01N1/30
To view Actuate Therapeutics’s complete patent history, request access »

Actuate Therapeutics Executive Team (10)

Name Title Board Seat Contact Info
Daniel Schmitt President, Chief Executive Officer & Board Member
John Marshall Scientific Advisor
Lee Ellis Scientific Advisor
Roger Cohen Scientific Advisor
Andrew Mazar Ph.D Co-Founder & Chief Operating Officer
You’re viewing 5 of 10 executive team members. Get the full list »

Actuate Therapeutics Board Members (8)

Name Representing Role Since
Aaron Fletcher Ph.D Self Chairman 000 0000
Daniel Zabrowski Ph.D Self Board Member 000 0000
Leslie Kreis Jr. Bios Partners Board Member 000 0000
Pascal Krotee Ph.D Kairos Ventures Board Member 000 0000
Todd Thomson Kairos Ventures Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Actuate Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Actuate Therapeutics Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
SeedFolio Venture Capital Minority 000 0000 000000 0
Sea Purity Investments Family Office Minority 000 0000 000000 0
DEFTA Partners Venture Capital Minority 000 0000 000000 0
Kairos Ventures Venture Capital Minority 000 0000 000000 0
Bios Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial